2026年7月1-3日，第 53 届日本毒性学会学术年会将在日本大阪举行。作为亚太地区最具影响力的毒理学学术盛会之一，本届年会吸引了来自全球的众多毒理学专家、科研人员及行业代表齐聚一堂，共同探讨毒理学研究的最新科学技术与前沿进展。会议设置数十场专题研讨会和科学会议，涵盖药物安全性评价、新方法技术开发、毒理机制研究等多个热点领域，并设有海报展示区及企业展览专区，为与会者给予全方位的学术研讨与产业合作平台。本届年会以‘不断演进的毒理学——多元领域交汇催生的创新’为主题，旨在促进跨学科的国际协作与知识共享，有助于毒理学研究与新药安全性评价的持续开展。”

时间：2026年7月1-3日
地点：大阪国际会议中心
黄金城集团展台：#73

01 Non-GLP & GLP Toxicology Studies

02 Histopathology

03 Clinical Pathology

04 Bioanalysis Servicesfor Small Molecules

Our bioanalysis services for small molecules, including peptide and oligonucleotide, support every phase of drug development from discovery to market. With over 20 years of regulatory experience and most advanced technologies and strategies, we deliver precise, on-time and high-quality data for PK, TK, PD, biodistribution, and biomarker assays. We specialize in developing and validating robust bioanalytical methods for the quantification of API and metabolites in various biological matrices, using LC-MS/MS with HPLC, UPLC etc.

05 Bioanalysis Services for Large Molecules

Our bioanalytical lab specializes in large molecule bioanalysis, offering comprehensive services including PK, TK, immunogenicity testing, and biomarker discovery. We have developed and validated 500+ bioanalytical methods for macromolecules including protein, antibody, ADC, peptide, CAR-T, CAR-NK, Lytic virus, etc. We also provide customized bioanalytical solutions, developing and validating unique methods to address specific large molecule research challenges.

06 SEND Data Submission

Medicilon's preclinical pharmacology and toxicology unit features a professional SEND format conversion team and a fully developed SEND data conversion platform (submit™ platform) encompassing software, technology, specifications, and quality control. This ensures accurate data conversion and facilitates seamless electronic data submission to the FDA.